Purple Biotech Financial Overview
Purple Biotech's market cap is currently $7.36M. The company's EPS TTM is $-0.29; its P/E ratio is -0.77; Purple Biotech is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $-0.34. See an overview of income statement, balance sheet, and cash flow financials.
